Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.
This buzzy natural filler promises subtle, low-risk results. We dig into what’s really in the syringe, who’s injecting it, and the risks you need to know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results